| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2121631 | European Journal of Cancer | 2015 | 12 Pages |
Abstract
TYAs with specific cancer diagnoses can be grouped according to 1- and 5-year survival patterns compared to children and young adults. To further improve survival for TYAs, age-specific biology, pharmacology, proteomics, genomics, clinician and patient behaviour studies embedded within clinical trials are required.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Dan Stark, David Bowen, Elaine Dunwoodie, Richard Feltbower, Rod Johnson, Anthony Moran, Charles Stiller, Catherine O'Hara,